Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Regencell Bioscience Holdings Limited

RGC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$26.99
$-2.18(-7.47%)
U.S. Market opens in 17h 27m

Regencell Bioscience Holdings Limited (RGC) Stock Overview

Explore Regencell Bioscience Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap13.3B
P/E Ratio-4063.01
EPS (TTM)$-0.01
ROE-0.62%
Fundamental Analysis

AI Price Forecasts

1 Month$48.58
3 Months$186.78
1 Year Target$57.13

RGC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Regencell Bioscience Holdings Limited (RGC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.58, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $57.13.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4063.01 and a market capitalization of 13.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-12.82%
5-Day Change
-6.69%
1-Month Change
19.94%
3-Month Change
131.14%
6-Month Change
136.58%
Year-to-Date (YTD) Change
42.02%
1-Year Change
-51.38%
3-Year Change
-51.38%
5-Year Change
-51.38%
All-Time (Max) Change
-51.38%

Contact Information

https://www.regencellbioscience.com
852 2155 0823
First Commercial Building, Causeway Bay, NaN, KY1-1107

Company Facts

120 Employees
IPO DateJul 16, 2021
CountryHK
Actively Trading

Frequently Asked Questions